EUR 18.05
(1.18%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3.05 Billion EUR | 33.44% |
2022 | 2.29 Billion EUR | 24.11% |
2021 | 1.84 Billion EUR | 21.13% |
2020 | 1.52 Billion EUR | -14.09% |
2019 | 1.77 Billion EUR | 18.35% |
2018 | 1.49 Billion EUR | 33.48% |
2017 | 1.12 Billion EUR | 7.88% |
2016 | 1.04 Billion EUR | 18.3% |
2015 | 880 Million EUR | 27.35% |
2014 | 691 Million EUR | -50.66% |
2013 | 1.4 Billion EUR | 1.33% |
2012 | 1.38 Billion EUR | -15.8% |
2011 | 1.64 Billion EUR | -12.2% |
2010 | 1.86 Billion EUR | 16.88% |
2009 | 1.59 Billion EUR | 8.62% |
2008 | 1.47 Billion EUR | -16.86% |
2007 | 1.77 Billion EUR | 19.84% |
2006 | 1.47 Billion EUR | 46.03% |
2005 | 1.01 Billion EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 786 Million EUR | 11.33% |
2024 Q1 | 706 Million EUR | 20.48% |
2023 FY | 3.05 Billion EUR | 33.44% |
2023 Q2 | 799 Million EUR | 4.17% |
2023 Q1 | 767 Million EUR | 223.63% |
2023 Q4 | 586 Million EUR | 8.72% |
2023 Q3 | 539 Million EUR | -32.54% |
2022 Q3 | 662 Million EUR | -5.16% |
2022 Q4 | 237 Million EUR | -64.2% |
2022 FY | 2.29 Billion EUR | 24.11% |
2022 Q2 | 698 Million EUR | 0.58% |
2022 Q1 | 694 Million EUR | 200.43% |
2021 Q2 | 429 Million EUR | -30.81% |
2021 FY | 1.84 Billion EUR | 21.13% |
2021 Q1 | 620 Million EUR | 121.43% |
2021 Q4 | 231 Million EUR | -59.19% |
2021 Q3 | 566 Million EUR | 31.93% |
2020 Q1 | 441 Million EUR | 88.46% |
2020 Q3 | 478 Million EUR | 47.08% |
2020 FY | 1.52 Billion EUR | -14.09% |
2020 Q4 | 280 Million EUR | -41.42% |
2020 Q2 | 325 Million EUR | -26.3% |
2019 Q1 | 617 Million EUR | 6270.0% |
2019 Q2 | 464 Million EUR | -24.8% |
2019 Q3 | 459 Million EUR | -1.08% |
2019 Q4 | 234 Million EUR | -49.02% |
2019 FY | 1.77 Billion EUR | 18.35% |
2018 Q2 | 350 Million EUR | -50.21% |
2018 Q4 | -10 Million EUR | -102.19% |
2018 Q3 | 456 Million EUR | 30.29% |
2018 FY | 1.49 Billion EUR | 33.48% |
2018 Q1 | 703 Million EUR | 1426.42% |
2017 Q2 | 321 Million EUR | -38.97% |
2017 Q1 | 526 Million EUR | 439.35% |
2017 Q4 | -53 Million EUR | -116.11% |
2017 Q3 | 329 Million EUR | 2.49% |
2017 FY | 1.12 Billion EUR | 7.88% |
2016 Q1 | 562 Million EUR | 1224.0% |
2016 FY | 1.04 Billion EUR | 18.3% |
2016 Q4 | -155 Million EUR | -143.91% |
2016 Q3 | 353 Million EUR | -58.13% |
2016 Q2 | 843 Million EUR | 50.0% |
2015 Q3 | 292 Million EUR | -54.23% |
2015 FY | 880 Million EUR | 27.35% |
2015 Q2 | 638 Million EUR | 31.82% |
2015 Q1 | 484 Million EUR | 1252.6% |
2015 Q4 | -50 Million EUR | -117.12% |
2014 FY | 691 Million EUR | -50.66% |
2014 Q1 | 264 Million EUR | -26.18% |
2014 Q3 | 227 Million EUR | -29.94% |
2014 Q2 | 324 Million EUR | 22.73% |
2014 Q4 | -41.99 Million EUR | -118.5% |
2013 Q4 | 357.63 Million EUR | 0.0% |
2013 FY | 1.4 Billion EUR | 1.33% |
2013 Q2 | 375.86 Million EUR | 0.0% |
2013 Q1 | 375.86 Million EUR | -7.63% |
2013 Q3 | 357.63 Million EUR | -4.85% |
2012 FY | 1.38 Billion EUR | -15.8% |
2012 Q4 | 406.89 Million EUR | 0.0% |
2012 Q3 | 406.89 Million EUR | 0.0% |
2011 FY | 1.64 Billion EUR | -12.2% |
2010 FY | 1.86 Billion EUR | 16.88% |
2009 FY | 1.59 Billion EUR | 8.62% |
2008 FY | 1.47 Billion EUR | -16.86% |
2007 FY | 1.77 Billion EUR | 19.84% |
2006 FY | 1.47 Billion EUR | 46.03% |
2005 FY | 1.01 Billion EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Bioera S.p.A. | -3.36 Million EUR | 90866.033% |
GPI S.p.A. | 27.78 Million EUR | -10901.547% |